Rebecca J Winter, Yumi Sheehan, Timothy Papaluca, Graeme A Macdonald, Joy Rowland, Anton Colman, Mark Stoove, Andrew R Lloyd and Alexander J Thompson Med J Aust 2023; 218 (5): 231-237. || doi: 10.5694/mja2.51854 Published online: 6 March 2023 Abstract Introduction: Prison settings represent the highest concentration of prevalent hepatitis C cases in Australia due to the high rates of...
NAPWHA (National Association of people with HIV Australia), July 2021 Despite access to effective ART and viral suppression, people living with HIV often report poor well-being and health-related quality of life. A multidisciplinary panel of 44 global HIV experts articulate how health systems can advance the long-term well-being of people living with HIV by addressing multi-morbidity, health...
Reframing Autism, June 17th 2021; Written by Sam Rose with Melanie Heyworth In recent years, it has become widely accepted that there is a considerable overlap between the Autistic and the LGBTIQA+ communities. However, a corresponding effort to support the Autistic-LGBTIQA+ community has not been forthcoming, and there is a striking lack of resource allocation, acceptance, and support for this...
Australian Federation of AIDS Organisations (AFAO), 17th June 2021 Agenda 2025 is a fully costed plan which draws upon evidence based research and is backed by top researchers, leaders, and clinicians in Australia’s community-led HIV response. Australia can end HIV transmission within four short years, averting over 6,000 infections by 2030 and saving $1.4 billion in health costs, according to a...
Intersex Human Rights Australia, 2nd October 2020 Austria has made a statement on behalf of countries from every region of the world, calling on the UN Human Rights Council to investigate and address human rights violations and abuses against intersex persons. Advocates from around the world worked with colleagues in ILGA World in Geneva to support this work. Read more (including the text and...
July/August 2020 The Therapeutic Goods Administration (TGA) advises: Consumers and health professionals are advised that there is a shortage of oral contraceptive pills containing the combination ethinylestradiol and norethisterone. The affected products are: Brevinor – norethisterone 0.5 mg and ethinylestradiol 35 micrograms Norimin – norethisterone 0.5 mg and ethinylestradiol 35...